Hippocampal asymmetry in angiotensin II modulatory effects on learning and memory in rats

• Autorzy: Tashev R. , Stefanova M.
• Języki publikacji: EN

Abstrakty

EN

Learning and memory effects of angiotensin II (Ang II) microinjected unilaterally (left or right) and bilaterally into hippocampal CA1 area on the background of the inhibited hippocampal angiotensin 1 receptors type (ATI) of male Wistar rats were studied. It was found that the combination (losartan 100 ^g + Ang II 0.5^g) microinjected bilaterally or into the left CA1 area improved learning and memory in shuttle-box and step through behavioral tests as compared to the respective controls. The effects were more pronounced after injection into the left CA1 area as compared to the right-side. These findings suggest thatAng II infused on the background of the inhibited CA1 hippocampal AT1 receptors ameliorated the cognitive processes. The data show also an asymmetric effect of Ang II on learning and memory processes in the hippocampus. The stronger modulating effect after microinjection of the combination (losartan + Ang II) into the left CA1 hippocampal area suggests a leftward bias in the rat. The results point to a differential distribution of angiotensin II receptors modulating the learning and memory processes in the left and right hippocampal CA1 area.

Słowa kluczowe

EN

brain; hippocampal asymmetry; hippocampus; angiotensin II; modulatory effect; losartan; learning; memory; rat; brain activity; renin-angiotensin system

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2015
• Tom: 75
• Numer: 1
• Opis fizyczny: p.48-59,fig.,ref.

Twórcy

autor

Tashev R.

• Department of Pathophysiology Medical University of Sofia, Sofia, Bulgaria
• Department of Behavioral Neurobiology, Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria

autor

Stefanova M.

• Department of Physiology and Pathophysiology, Medical University, Varna, Bulgaria

Bibliografia

• Akhavan MM, Emami-Abarghoie M, Sadighi-Moghaddam B, Safari M, Yousefi Y, Rashidy-Pour A (2008) Hippocampal angiotensin II receptors play an important role in mediating the effect of voluntary exercise on learning and memory in rat. Brain Res 1232: 132-138.
• Albiston AL, Mc Dowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FA, Simpson RJ, Connolly LM, Chai SY (2001) Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated amino- peptidase. J Biol Chem 276: 48623-48626
• Albiston AL, Fernando R, Ye S, Peck GR, Chai SY (2004) Alzheimer's, angiotensin IV and an aminopeptidase. Biol Pharm Bull 27: 765-767.
• Albrecht D (2010) Physiological and pathophysiological functions of different angiotensins in the brain. Br J Pharmacol 159: 1392-1401.
• Alexander SP, Mathie A, Peters JA (2008) Guide to recep­tors and channels (GRAC), 3rd edition. Br J Pharmacol 153 Suppl 2: S1-209.
• Armstrong DL, Garcia EA, Ma T, Quinones B, Wayner MJ (1996) Angiotensin II blockade of long-term potentiation at the perforant path--granule cell synapse in vitro. Peptides 17: 689-693.
• Baranowska D, Braszko JJ, Wisniewski K (1983) Effect of angiotensin II and vasopressin on acquisition and extinc­tion of conditioned avoidance in rats. Psychopharmacology (Berl) 81: 247-251.
• Belcheva I, Chobanova M, Georgiev V (1998) Differential behavioral effects of angiotensin II microinjected unilater­ally into the CA1 hippocampal area. Regul Pept 74: 67-71.
• Belcheva I, Ternianov A, Georgiev V (2000) Lateralized learning and memory effects of angiotensin II microin- jected into the rat CA1 hippocampal area. Peptides 21: 407-411.
• Belcheva S, Tashev R, Hadjiivanova C, Belcheva I (2007) Modulation of learning and memory by CI-988 cholecys- tokinin octapeptide antagonist microinjected into CA1 hippocampal area. Comptes rendus de l'Acade'mie bul­gare des Sciences 60: 1337-1342.
• Bild W, Ciobica A (2013) Angiotensin-(1-7) central admin­istration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala. J Affect Disord 145: 165-171.
• Bild W, Hritcu L, Stefanescu C, Ciobica A (2013) Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 43: 79-88.
• Braszko JJ (2002) AT(2) but not AT(1) receptor antagonism abolishes angiotensin II increase of the acquisition of conditioned avoidance responses in rats. Behav Brain Res 131: 79-86.
• Braszko JJ (2009) Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroven- tricular angiotensin IV and des-Phe(6)-Ang IV in rats. Eur Neuropsychopharmacol 19: 85-91.
• Braszko JJ, Wisniewski K (1988) Effect of angiotensin II and saralasin on motor activity and the passive avoidance behavior of rats. Peptides 9: 475-479.
• Braszko JJ, J Wlasienko J, Kupryszewski G, Witczuk B, Wisniewski K (1988a) Behavioral effects of angiotensin II and angiotensin II-(4-8)-pentapeptide in rats. Physiol Behav 44: 327-332.
• Braszko JJ, Kupryszewski G, Witczuk B, Wisniewski K (1988b) Angiotensin II-(3-8)-hexapeptide affects motor activity, per­formance of passive avoidance and a conditioned avoidance response in rats. Neuroscience 27: 777-783.
• Braszko JJ, Walesiuk A, Wielgat P (2006) Cognitive effects attributed to angiotensin II may result from its conversion to angiotensin IV. J Renin Angiotensin Aldosterone Syst 7: 168-174.
• Bregonzio C, Seltzer A, Armando I, Pavel J, Saavedra JM (2008) Angiotensin II AT(1) receptor blockade selectively enhances brain AT(2) receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontane­ously hypertensive rats. Stress 11: 457-466.
• Buresova O, Bures J (1983) Techniques and Basic Experiments for the Study of Brain and Behavior (2nd rev) (Bures J, Buresova O, Huston JP, Eds). Elsevier Science Publishers, New York, NY, USA.
• Castren E, Saavedra JM (1988) Repeated stress increases the density of angiotensin II binding sites in rat paraventricu- lar nucleus and subfornical organ. Endocrinology 122: 370-372.
• Chai SY, Fernando R, Peck G, Ye SY, Mendelsohn FA, Jenkins TA, Albiston AL (2004) The angiotensin IV/AT4 receptor. Cell Mol Life Sci 61: 2728-2737.
• Chalas A, Conway EL (1996) No evidence for involvement of angiotensin II in spatial learning in water maze in rats. Behav Brain Res 81: 199-205.
• Chappell MC, Brosnihan KB, Diz DI, Ferrario CM (1989) Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J Biol Chem 264: 16518-16523.
• Chrysant SG ( 2007) The pathophysiologic role of the brain renin-angiotensin system in stroke protection: clinical implications. J Clin Hypertens (Greenwich) 9: 454-459.
• Culman J, Baulmann J, Blume A, Unger T (2001) The renin- angiotensin system in the brain: an update. J Renin Angiotensin Aldosterone Syst 2: 96-102.
• Culman J, Blume A, Gohlke P, Unger T (2002) The renin- angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers. J Hum Hypertens 16 Suppl 3: S64-70.
• Danielyan L, Klein R, Hanson LR, Buadze M, Schwab M, Gleiter CH, Frey WH (2010) Protective effects of intrana­sal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease. Rejuvenation Res 13: 195-201.
• Davis CJ, Kramar EA, De A, Meighan PC, Simasko SM, Wright JW, Harding JW (2006) AT4 receptor activation increases intracellular calcium influx and induces a non- N-methyl-D-aspartate dependent form of long-term potentiation. Neuroscience 137: 1369-1379.
• De Bundel D, Demaegdt H, Lahoutte T, Caveliers V, Kersemans K, Ceulemans AG,Vauquelin G, Clinckers R, Vanderheyden P, Michotte Y, et al. (2010) Involvementof the AT1 receptor subtype in the effects of angiotensin IV and LVV-haemorphin7 on hippocampal neurotransmitter levels and spatial working memory. J Neurochem112: 1223-1234.
• De Bundel D, Smolders I, Vanderheyden P, Michotte Y (2008) Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy. CNS Neurosci Ther 14: 315-339.
• de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472.
• Denny JB, Polan-Curtain J, Wayner MJ, Armstrong DL (1991) Angiotensin II blocks hippocampal long-term potentiation. Brain Res 567: 321-324.
• Du GT, Hu M, Mei ZL, Wang C, Liu GJ, Hu M, Long Y, Miao MX, Chang Li J, Hong H (2014) Telmisartan treat­ment ameliorates memory deficits in streptozotocin-in- duced diabetic mice via attenuating cerebral amyloidosis. J Pharmacol Sci 124: 418-426.
• Duron E, Hanon O (2010) Antihypertensive treatments, cog­nitive decline, and dementia. J. Alzheimers Dis 20: 903-914.
• Freund M, Walther T, von Bohlen und Halbach O (2012) Immunohistochemical localization of the angiotensin- (1-7) receptor Mas in the murine forebrain. Cell Tissue Res 348: 29-35.
• Gallo-Payet N, Guimond MO, Bilodeau L, Wallinder C, Alterman M,Hallberg A (2011) Angiotensin II, a neuro- peptide at the frontier between endocrinology and neuro­science: is there a link between the angiotensin II type 2 receptor and Alzheimer's disease? Front Endocrinol (Lausanne) 2: 17.
• Gard PR (2002) The role of angiotensin II in cognition and behaviour. Eur J Pharmacol 438: 1-14.
• Gard PR (2008) Cognitive-enhancing effects of angiotensin IV BMC Neurosci 9 Suppl 2: S15.
• Georgiev V (1990) Involvement of transmitter mechanisms in the behavioural effects of angiotensin II. Pol J Pharmacol Pharm 42: 553-562.
• Georgiev VP, Yonkov DI, Kambourova TS (1988) Interactions between angiotensin II and baclofen in shuttle-box and passive avoidance performance. Neuropeptides 12: 155­158.
• Gozzani JL, Izquierdo I (1976) Possible peripheral adrener- gic and central dopaminergic influences in memory con­solidation. Psychopharmacology (Berl) 49: 109-111.
• Guimond MO, Gallo-Payet N (2012) How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations? Front Endocrinol (Lausanne) 3: 164.
• Haas HL, Felix D, Celio MR, Inagami T (1980) Angiotensin II in the hippocampus. A histochemical and electrophysi- ological study. Experientia 36: 1394-1395.
• Hellner K, Walther T, Schubert M, Albrecht D (2005) Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas. Mol Cell Neurosci 29: 427-435.
• Inaba S, Iwai M, Furuno M, Tomono Y, Kanno H, Senba I, Okayama H, Mogi M, Higaki J, Horiuchi M (2009) Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice. Hypertension 53: 356-362.
• Ivanova M, Ternianov A, Belcheva S, Tashev R, Negrev N, Belcheva I (2008) Hippocampal asymmetry in explor­atory behavior to vasoactive intestinal polypeptide. Peptides 29: 940-947.
• Jing F, Mogi M, Sakata A, Iwanami J, Tsukuda K, Ohshima K, Min LJ, Steckelings UM, Unger T, Dahlof B, Horiuchi M (2012) Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J Cereb Blood Flow Metab 32: 248-255.
• Jing G, Grammatopoulos T, Ferguson P, Schelman W, Weyhenmeyer J (2004) Inhibitory effects of angiotensin on NMDA-induced cytotoxicity in primary neuronal cul­tures. Brain Res Bull 62: 397-403.
• Kerr DS, Bevilaqua LR, Bonini JS, Rossato JI, Kohler CA, Medina JH, Izquierdo I, Cammarota M (2005) Angiotensin
• II blocks memory consolidation through an AT2 receptor- dependent mechanism. Psychopharmacology (Berl) 179: 529-535.
• Kramar EA, Armstrong DL, Ikeda S, Wayner MJ, Harding JW, Wright JW (2001) The effects of angiotensin IV ana­logs on long-term potentiation within the CA1 region of the hippocampus in vitro. Brain Res 897: 114-121.
• Krizanova O, Kiss A, Zacikova L, Jezova D (2001) Nitric oxide synthase mRNA levels correlate with gene expres­sion of angiotensin II type-1 but not type-2 receptors, renin or angiotensin converting enzyme in selected brain areas. Physiol Res 50: 473-480.
• Kulakowska A, Karwowska W, Wisniewski K, Braszko JJ (1996) Losartan influences behavioural effects of angio­tensin II in rats. Pharmacol Res 34: 109-115.
• Lee EH, Ma YL, Wayner MJ, Armstrong DL (1995) Impaired retention by angiotensin II mediated by the AT1 receptor. Peptides 16: 1069-1071.
• Lee J, Chai SY, Mendelsohn FA, Morris MJ, Allen AM (2001) Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7. Neuropharmacology 40: 618-623.
• Llorens-Cortes C, Mendelsohn FA (2002) Organisation and functional role of the brain angiotensin system. J Renin Angiotensin Aldosterone Syst 3 Suppl 1: S39-48.
• Martin SJ, Grimwood PD, Morris RG (2000) Synaptic plas­ticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci 23: 649-711.
• Mogi M, Iwanami J, Horiuchi M (2012) Roles of brain angiotensin II in cognitive function and dementia. Int J Hypertens 2012: 169649.
• Morgan JM, Routtenberg A (1977) Angiotensin injected into the neostriatum after learning disrupts retention perfor­mance. Science 196: 87-89.
• Mukuda T, Sugiyama H (2007) An angiotensin II receptor antagonist suppresses running-enhanced hippocampal neurogenesis in rat. Neurosci Res 58: 140-144.
• Paris JJ, Eans SO, Mizrachi E, Reilley KJ, Ganno ML, McLaughlin JP (2013) Central administration of angio- tensin IV rapidly enhances novel object recognition among mice. Neuropharmacology 70: 247-253.
• Pederson ES, Harding JW, Wright JW (1998) Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog. Regulatory Peptides 74: 97-103.
• Pellegrino L, Cushman A (1967) A Stereotaxic Atlas of the Rat Brain. Appleton-Century-Crofts, New York, NY, USA
• Reagan LP, Flanagan-Cato LM, Yee DK, Ma LY, Sakai RR, Fluharty SJ (1994) Immunohistochemical mapping of angiotensin type 2 (AT2) receptors in rat brain. Brain Res 662: 45-59.
• Rowe BP, Grove KL, Saylor DL, Speth RC (1991) Discrimination of angiotensin II receptor subtype distri­bution in the rat brain using non-peptidic receptor antago­nists. Regul Pept 33: 45-53.
• Saavedra JM, Sanchez-Lemus E, Benicky J (2011) Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications. Psychoneuroendocrinology 36: 1-18.
• Santos RA, Campagnole-Santos MJ, Andrade SP (2000) Angiotensin-(1-7): an update. Regul Pept 91: 45-62.
• Santos RAS, Silva ACS, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100:8258-8263
• Savaskan E, Hock C, Olivieri G, Bruttel S, Rosenberg C, Huylette C, Muller-Spahn F (2001) Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia. Neurobiol Aging 22: 541-546.
• Schelman WR, Kurth JL, Berdeaux RL, Norby SW, Weyhenmeyer JA (1997) Angiotensin II type-2 (AT2) receptor-mediated inhibition of NMDA receptor signal­ling in neuronal cells. Brain Res Mol Brain Res 48: 197-205.
• Schelman WR, Andres R, Ferguson P, Orr B, Kang E, Weyhenmeyer JA (2004) Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression. Brain Res Mol Brain Res 128: 20-29.
• Sharma B, Singh N (2012) Experimental hypertension induced vascular dementia: pharmacological, biochemi­cal and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor. Pharmacol Biochem Behav 102: 101-108.
• Shepherd J, Bill DJ, Dourish CT, Grewal SS, McLenachan A, Stanhope KJ (1996) Effects of the selective angio­tensin II receptor antagonists losartan and PD123177 in animal models of anxiety and memory. Psychopharmacology (Berl) 126: 206-218.
• Sirett NE, Bray JJ, Hubbard JI (1981) Localization of immu- noreactive angiotensin II in the hippocampus and stria- tum of rat brain. Brain Res 217: 405-411.
• Tchekalarova J, Albrecht D (2007) Angiotensin II sup­presses long-term depression in the lateral amygdala of mice via L-type calcium channels. Neurosci Lett 415: 68-72.
• Tsukuda K, Mogi M, Iwanami J, Min LJ, Sakata A, Jing F, Iwai M, Horiuchi M (2009) Cognitive deficit in amyloid- beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation. Hypertension 54: 782-787.
• Vanderheyden PM (2009) From angiotensin IV binding site to AT4 receptor. Mol Cell Endocrinol 302: 159-166.
• Vauquelin G, Michotte Y, Smolders I, Sarre S, Ebinger G, Dupont A, Vanderheyden P (2002) Cellular targets for angio- tensin II fragments: pharmacological and molecular evi­dence. J Renin Angiotensin Aldosterone Syst 3: 195-204.
• von Bohlen und Halbach O (2003) Angiotensin IV in the central nervous system. Cell Tissue Res 311: 1-9.
• von Bohlen und Halbach O, Albrecht D (1998) Mapping of angiotensin AT1 receptors in the rat limbic system. Regul Pept 78: 51-56.
• von Bohlen und Halbach O, Albrecht D (2006) The CNS renin-angiotensin system. Cell Tissue Res 326: 599-616.
• Von Bohlen und Halbach O, Walther T, Bader M, Albrecht D (2000) Interaction between Mas and the angiotensin AT1 receptor in the amygdala. J Neurophysiol 83: 2012­2021.
• Wayner MJ, Armstrong DL, Polan-Curtain JL, Denny JB (1993) Role of angiotensin II and AT1 receptors in hip- pocampal LTP. Pharmacol Biochem Behav 45: 455-464.
• Wayner MJ, Polan-Curtain J, Armstrong DL (1995) Dose and time dependency of angiotensin II inhibition of hippocam- pal long-term potentiation. Peptides 16: 1079-1082.
• Wayner MJ, Phelix CF, Armstrong DL (1997) Lateral hypo­thalamic stimulation inhibits dentate granule cell LTP: direct connections. Brain Res Bull 43: 5-15.
• Wayner MJ, Armstrong DL, Phelix CF, Wright JW, Harding JW (2001) Angiotensin IV enhances LTP in rat dentate gyrus in vivo. Peptides 22: 1403-1414.
• Wilson WL, Munn C, Ross RC, Harding JW, Wright JW (2009) The role of the AT4 and cholinergic systems in the Nucleus Basalis Magnocellularis (NBM): effects on spa­tial memory. Brain Res 1272: 25-31.
• Wisniewski J, Braszko JJ (1984) The significance of central monoamine systems in the angiotensin II (AII) improve­ment of learning. Clin Exp Hypertens A 6: 2127-2131.
• Wright JW, Harding JW (1995) Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions. Regul Pept 59: 269-295.
• Wright JW, Harding JW (2008) The angiotensin AT4 recep­tor subtype as a target for the treatment of memory dys- function associated with Alzheimer's disease. J Renin Angiotensin Aldosterone Syst 9: 226-237.
• Wright JW, Harding JW (2011) Brain renin-angiotensin - a new look at an old system. Prog Neurobiol 95: 49-67.
• Wright JW, Miller-Wing AV, Shaffer MJ, Higginson C, Wright DE, Hanesworth JM, Harding JW (1993) Angiotensin II(3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory. Brain Research Bulletin 32 : 497-502.
• Wright JW, Stubley L, Pederson ES, Kramar EA, Hanesworth JM, Harding JW (1999) Contributions of the brain angio­tensin IV-AT4 receptor subtype system to spatial learn­ing. J Neurosci 19: 3952-3961
• Wright JW, Yamamoto BJ, Harding JW (2008) Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets. Prog Neurobiol 84: 157-181.
• Wu L, Iwai M, Nakagami H, Chen R, Suzuki J, Akishita M, de Gasparo M, Horiuchi M (2002) Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Arterioscler Thromb Vasc Biol 22: 49-54.
• Yang H, Raizada MK (1999) Role of phosphatidylinosi- tol 3-kinase in angiotensin II regulation of norepi- nephrine neuromodulation in brain neurons of the spontaneously hypertensive rat. J Neurosci 19: 2413­2423.
• Yonkov DI, Georgiev VP (1990) Cholinergic influence on memory facilitation induced by angiotensin II in rats. Neuropeptides 16: 157-162.
• Yonkov DI, Georgiev VP, Opitz MJ (1986) Participation of angiotensin II in learning and memory. II. Interactions of angiotensin II with dopaminergic drugs. Methods Find Exp Clin Pharmacol 8: 203-206.
• Yonkov D, Georgiev V, Kambourova T, Opitz M (1987) Participation of angiotensin II in learning and memo­ry. III. Interactions of angiotensin II with GABAergic drugs. Methods Find Exp Clin Pharmacol 9: 205­208.
• Yonkov D, Georgiev V, Kambourova T (1989) Further evi­dence for the GABAergic influence on memory. Interaction of GABAergic transmission with angiotensin II on memory processes. Methods Find Exp Clin Pharmacol 11: 603-606.